Turnover rate of tear-film lipid layer determined by fluorophotometry.
OBJECTIVE
This study was performed to independently assess the turnover rates of aqueous and lipid layers of the tear film.


METHODS
Two fluorescent dyes, fluorescein sodium and 5-dodecanoylaminofluorescein (DAF), which is a free-fatty-acid conjugate of fluorescein, were applied to the right eye of 12 healthy volunteers. Fluorescent intensity of the precorneal tear film was measured at the central cornea every minute for 10 min for fluorescein sodium, and every 5 min for 50 min for DAF. The turnover rate was calculated by plotting fluorescent intensity against time in a semilog plot and expressed as %/min.


RESULTS
Turnover rates of fluorescein sodium and DAF were 10.3 (SD 3.7)%/min and 0.93 (0.36)%/min, respectively. The turnover rate of DAF was significantly lower than that of fluorescein sodium (p<0.05, Mann-Whitney test). The turnover rate of DAF positively correlated with that of fluorescein sodium (r = 0.93, p<0.05).


CONCLUSIONS
Our results indicate that the turnover of lipids in tears is much slower than the aqueous flow of tears, and that this lipid turnover is associated with the aqueous flow of tears in healthy adults.
Mochizuki
H
H
Division for Vision Research, National Institute of Sensory Organs, National Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8902, Japan.
Yamada
M
M
Hatou
S
S
Tsubota
K
K
D000328:Adult; D005260:Female; D019793:Fluorescein; D005452:Fluoresceins; D005456:Fluorescent Dyes; D015590:Fluorophotometry / Q000379:methods; D006801:Humans; D050356:Lipid Metabolism / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D013666:Tears / Q000378:metabolism*; D055815:Young Adult
C503505:5-dodecanoylaminofluorescein; D005452:Fluoresceins; D005456:Fluorescent Dyes; D019793:Fluorescein
Acta Ophthalmol (Copenh). 1979 Oct;57(5):766-74
525300
Exp Eye Res. 2004 Mar;78(3):347-60
15106912
Am J Ophthalmol. 2006 Apr;141(4):669-75
16564801
Optom Vis Sci. 1997 Jan;74(1):8-13
9148269
Br J Ophthalmol. 2008 Jan;92(1):108-11
18156377
Exp Eye Res. 1961 Sep;1:39-45
14474548
Curr Eye Res. 1995 May;14(5):363-72
7648862
Adv Exp Med Biol. 2002;506(Pt A):373-8
12613936
Exp Eye Res. 1983 Jan;36(1):25-33
6825731
Cornea. 1994 Jul;13(4):354-9
7924337
Invest Ophthalmol. 1966 Jun;5(3):264-76
5947945
Ophthalmology. 1996 Apr;103(4):664-9
8618768
Am J Ophthalmol. 1996 Dec;122(6):818-24
8956636
Exp Eye Res. 2004 Mar;78(3):399-407
15106919
Invest Ophthalmol Vis Sci. 2009 Jan;50(1):140-51
18757516
Invest Ophthalmol Vis Sci. 1992 Sep;33(10):2942-50
1526744
Curr Eye Res. 1993 Mar;12(3):255-9
8482114
Curr Eye Res. 1993 Mar;12(3):247-54
8482113
Optom Vis Sci. 2002 Jun;79(6):363-9
12086302
Br J Ophthalmol. 2005 Jul;89(7):803-5
15965153
Curr Eye Res. 1999 Jul;19(1):4-11
10415451
Invest Ophthalmol Vis Sci. 1999 Dec;40(13):3100-7
10586930
Trans Am Ophthalmol Soc. 1997;95:79-88; discussion 88-93
9440164